RVMD Earnings Results and History
Revolution Medicines, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- Revenue$197.6M
- Net income−$407.5M
- EPS (GAAP)−$1.90
Filed Nov 4, 2026. The next earnings release shows here within a minute of filing.
EPS by quarter
GAAP diluted, 12 quartersRevenue and operating margin
from 10-Q and 10-KQuarter by quarter
from 10-Q and 10-K filings| Quarter ended | Revenue | Growth | Gross margin | Op margin | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2026 | $197.6M | – | 99.8% | −188.9% | −$407.5M | −$1.90 | −$419.3M |
| Dec 2025 | $0 | – | – | – | −$364.9M | −$1.89 | −$276.2M |
| Sep 2025 | $0 | – | – | – | −$305.2M | −$1.61 | −$210.7M |
| Dec 2024 | $0 | −100.0% | – | – | −$194.6M | −$1.13 | −$139.5M |
EPS here is GAAP diluted, as filed with the SEC. Estimates are usually based on adjusted EPS, so the two can differ. Growth compares with the same quarter a year earlier.
Reports and price reactions
last 1 reportsYear by year
fiscal years, from 10-K filings| Year ended | Revenue | Growth | Op margin | Net income | EPS |
|---|---|---|---|---|---|
| Dec 31, 2025 | $0 | – | – | −$1.13B | −$5.95 |
| Dec 31, 2024 | $0 | −100.0% | – | −$600.1M | −$3.58 |
| Dec 31, 2023 | $11.6M | −67.3% | −4207.1% | −$436.4M | −$3.86 |
| Dec 31, 2022 | $35.4M | +20.4% | −730.0% | −$248.7M | −$3.08 |
| Dec 31, 2021 | $29.4M | – | −639.7% | −$187.1M | −$2.57 |
Filings and dates
SEC EDGAR- Nov 4, 2026Quarterly report10-Q All filings
Also see RVMD institutional ownership and the earnings calendar.
RVMD earnings FAQ
When is RVMD's next earnings date?
There is no confirmed date on our calendar yet. Most companies report about four to six weeks after each quarter ends.
Is RVMD's revenue growing?
In the quarter ended Sep 30, 2026 revenue was $197.6M. The table on this page shows every quarter from the company's 10-Q and 10-K filings.
Where do these numbers come from?
Results, guidance and financials come from Revolution Medicines, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways summarize the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways summarize the company's press release and may contain errors; the press release is the authoritative source.